2451-91-4

Usage

Synthesis Reference(s)

Synthesis, p. 882, 1978 DOI: 10.1055/s-1978-24922

InChI:InChI=1/C15H14N2/c16-13-17(11-14-7-3-1-4-8-14)12-15-9-5-2-6-10-15/h1-10H,11-12H2

Upstream product

• 506-68-3 bromocyane 
• 620-40-6 tribenzylamine 
• 36289-36-8 N-cyanoimidazole 
• 103-49-1 dibenzylamine 
• 622-77-5 N-benzylcyanamide 
• 506-77-4 cyanogen chloride 
• 58288-30-5 N,N,N′,N′-tetrabenzylmethanediamine 
• 22014-91-1 3-(dibenzylamino)prop-1-ene 
• 100-46-9 benzylamine 
• 100-39-0 benzyl bromide 
• 6926-50-7 1-benzyl-1H-tetrazole 
• 1176290-06-4 N-(3-methyl-2-buten-1-yl)-dibenzylamine 
• 7677-24-9 trimethylsilyl cyanide 
• 100-44-7 benzyl chloride 

Downstream Products

• 35140-85-3 N,N-Dibenzyl-O-methyl-isoharnstoff 
• 40683-83-8 N¹,N¹-Dibenzyl-N²-(chlorsulfuryl)-chlorformamidin 
• 93795-56-3 2-Dibenzylamino-6-p-tolyl-[1,3]oxazin-4-one 
• 93795-58-5 6-(4-Bromo-phenyl)-2-dibenzylamino-[1,3]oxazin-4-one 
• 103-49-1 dibenzylamine 
• 127099-85-8 N-Cyanoguanidine 
• 108-88-3 toluene 
• 255724-11-9 N,N-dibenzylselenourea 
• 1323947-54-1 dimethyl 3-(dibenzylamino)-1,4-dimethyl-5H-cyclopenta[c]pyridine-6,6(7H)-dicarboxylate 
• 1422357-59-2 N,N-dibenzyl-4,7-dimethyl-2-tosyl-2,3-dihydro-1H-pyrrolo[3,4-c]-pyridin-6-amine 
• 36283-82-6 3-hydroxy-4-(2,4,2',4'-tetrahydroxy-benzhydrylidene)-cyclohexa-2,5-dienone 

Relevant academic research and scientific papers

Cyanide-Free Synthesis of Air Stable N-Substituted Li and K Cyanamide Salts from Tetrazoles. Applications toward the Synthesis of Primary and Secondary Cyanamides as Precursors to Amidines

A practical two-step synthesis of N,N′-disubstituted cyanamides consists in the low-temperature metalation of N-substituted 5H-tetrazoles that undergo spontaneous cycloreversion at 0 °C releasing dinitrogen, and forming N-metalated cyanamides that can be reacted in situ with a variety of electrophiles. Remarkably, the N-substituted Li and K cyanamides are air stable white solids at room temperature. Addition of lithium organometallics to the N,N′-disubstituted cyanamides provides a new method for accessing N,N′-disubstituted amidines.

Tris(3,5-dimethylpyrazolyl)methane copper(I) complexes featuring one disubstituted cyanamide ligand

The complexes [Cu{HC(3,5-Me2pz)3}(NCNR2)][BF4] (1–8; R2 = Me2 1, Et2 2, C5H10 3, C4H8O 4, C4H8 5, C3H

A allyl uncle amine compound by one-step synthesis method of cyano uncle amine compound (by machine translation)

The invention relates to a one-step synthesis of amine compound allyl unclecyano uncle amine compounds, which belongs to the technical field of organic synthetic method. The method specific synthetic process is as follows: in the airtight reaction environment, to the anhydrous organic solvent is added in the cyanogen bromide, under protection of inert gas, and then added dropwise to the solution in the allylic and high yield amine compound, to obtain allyl uncle amine compound concentration is 0.8 - 1 mol/L solution, at room temperature the reaction 16 - 24 hours later, after column chromatography separation and purification, to obtain a corresponding cyano uncle amine compound. The method to get rid of the expensive deallylation use of the catalyst, the synthesis step is less, raw materials are easy, cheap, mild reaction conditions, the operation is simple, easy to craft and industrialization. Yield 50% - 80% between. (by machine translation)

Synthesis of Cyanamides from Cyanogen Bromide under Mild Conditions through N-Cyanation of Allylic Tertiary Amines

Cyanamides were selectively formed through a one-step nucleophilic substitution reaction of allylic tertiary amines with cyanogen bromide. Because of the mild reaction conditions and good yields of the reaction, as well as the commercial availability of the starting materials, this new method represents a valuable tool for the synthesis of cyan-amides through an N-deallylation reaction and an N-cyanation reaction in one pot.

N-Cyanation of Secondary Amines Using Trichloroacetonitrile

A one-pot N-cyanation of secondary amines has been developed using trichloroacetonitrile as an inexpensive cyano source. A diverse range of cyclic and acyclic secondary amines can be readily transformed into the corresponding cyanamides in good isolated yields, with the method successfully utilized in the final synthetic step of a biologically active rolipram-derived cyanamide. This approach exhibits distinct selectivity when compared to the use of highly toxic cyanogen bromide.

A copper-mediated oxidative N-cyanation reaction

Copper-promoted N-cyanation of aliphatic sec-amine by CuCN is achieved via oxidative coupling. This procedure employs O2 as a clean oxidant. Notably, sulfoximines and 1,1,3,3-tetramethylguanidine also worked well in this procedure. Thus, it represents a key progress in the C-N bond formation reaction as well as in the cyanation reaction. This journal is the Partner Organisations 2014.

A simple method for the electrophilic cyanation of secondary amines

Bleach oxidizes trimethylsilyl cyanide to generate an electrophilic cyanating reagent that readily reacts with an amine nucleophile. This oxidative N-cyanation reaction allows for the preparation of disubstituted cyanamides from amines without using highly toxic cyanogen halides.

A facile synthesis of 3-trifluoromethyl-1,2,4-oxadiazoles from cyanamides

A safe and facile method for the formation of 3-trifluoromethyl-5-amino-1, 2,4-oxadiazoles, via a reversed addition of hydroxylamine to cyanamides, is reported. This two-pot procedure is suitable to scale-up and avoids the hazards associated with trifluor

Dibenzyl Amine Compounds and Derivatives

Dibenzyl amine compounds and derivatives, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid le

Dibenzyl Amine Compounds and Derivatives

Dibenzyl amine compounds and derivatives, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.